248 related articles for article (PubMed ID: 32197933)
1. Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder.
Cicek N; Yildiz N; Alpay H
J Pediatr Urol; 2020 Jun; 16(3):366.e1-366.e5. PubMed ID: 32197933
[TBL] [Abstract][Full Text] [Related]
2. Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization.
Huen KH; Nik-Ahd F; Chen L; Lerman S; Singer J
J Pediatr Urol; 2019 Apr; 15(2):178.e1-178.e7. PubMed ID: 30611650
[TBL] [Abstract][Full Text] [Related]
3. Randomized Clinical Trial Using Sterile Single Use and Reused Polyvinylchloride Catheters for Intermittent Catheterization with a Clean Technique in Spina Bifida Cases: Short-Term Urinary Tract Infection Outcomes.
Madero-Morales PA; Robles-Torres JI; Vizcarra-Mata G; Guillén-Lozoya AH; Mendoza-Olazarán S; Garza-González E; Gutiérrez-González A
J Urol; 2019 Jul; 202(1):153-158. PubMed ID: 30916625
[TBL] [Abstract][Full Text] [Related]
4. Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladder- a single-center retrospective observational study.
Mouhssine M; Al Ani D; Al Shibli A; Ghatasheh G; Al Amri A; Matta H; Chedid R; Narchi H
J Pediatr Urol; 2023 Feb; 19(1):64.e1-64.e7. PubMed ID: 36216695
[TBL] [Abstract][Full Text] [Related]
5. Association between clean intermittent catheterization and urinary tract infection in infants and toddlers with spina bifida.
Kaye IY; Payan M; Vemulakonda VM
J Pediatr Urol; 2016 Oct; 12(5):284.e1-284.e6. PubMed ID: 27118581
[TBL] [Abstract][Full Text] [Related]
6. [The consequence after introduction of clean intermittent catheterization (CIC) in children with neurogenic bladder dysfunction secondary to spina bifida--the comparison of patients with and without upper urinary tract dilation at the time CIC was introduced].
Obara K; Komeyama T; Mizusawa T; Tsutsui T; Wakatsuki H; Arai K; Kosegawa E; Suzuki K; Takahashi K
Nihon Hinyokika Gakkai Zasshi; 2003 Nov; 94(7):664-70. PubMed ID: 14671996
[TBL] [Abstract][Full Text] [Related]
7. The impact of constant antibiotic prophylaxis in children affected by spinal dysraphism performing clean intermittent catheterization: a 2-year monocentric retrospective analysis.
Mariani F; Ausili E; Zona M; Grotti G; Curatola A; Gatto A; Rendeli C
Childs Nerv Syst; 2022 Mar; 38(3):605-610. PubMed ID: 34523011
[TBL] [Abstract][Full Text] [Related]
8. Urinary tract infections in children with spina bifida: an inventory of 41 European centers.
Zegers BS; Winkler-Seinstra PL; Uiterwaal CS; de Jong TV; Kimpen JL; de Jong-de Vos van Steenwijk CC
Pediatr Nephrol; 2009 Apr; 24(4):783-8. PubMed ID: 19066975
[TBL] [Abstract][Full Text] [Related]
9. Predominant bacteria and patterns of antibiotic susceptibility in urinary tract infection in children with spina bifida.
Ortiz TK; Velazquez N; Ding L; Routh JC; Wiener JS; Seed PC; Ross SS
J Pediatr Urol; 2018 Oct; 14(5):444.e1-444.e8. PubMed ID: 29709445
[TBL] [Abstract][Full Text] [Related]
10. Risk of prolapse and urinary complications in adult spina bifida patients with neurogenic acontractile detrusor using clean intermittent catheterization versus Valsalva voiding.
El Akri M; Brochard C; Hascoet J; Jezequel M; Alimi Q; Khene ZE; Richard C; Bonan I; Kerdraon J; Gamé X; Manunta A; Siproudhis L; Peyronnet B
Neurourol Urodyn; 2019 Jan; 38(1):269-277. PubMed ID: 30311685
[TBL] [Abstract][Full Text] [Related]
11. Management of urinary tract infection with intravesical amikacin may increase the risk of bladder oxidative stress in children with neurogenic bladder.
Amasyali AS; Yilmaz D; Yilmaz M; Kucukdurmaz F; Sonmez F; Erol H
Int Urol Nephrol; 2017 Dec; 49(12):2105-2109. PubMed ID: 28956280
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Associated With Recurrent Urinary Tract Infection in Neurogenic Bladders Managed by Clean Intermittent Catheterization.
Chaudhry R; Balsara ZR; Madden-Fuentes RJ; Wiener JS; Routh JC; Seed P; Ross SS
Urology; 2017 Apr; 102():213-218. PubMed ID: 28065810
[TBL] [Abstract][Full Text] [Related]
13. The use of intravesical hyaluronic acid for recurrent urinary tract infections in children: a case-series study.
Fidan K; Büyükkaragöz B; Özen O; Demirogullari B; Söylemezoglu O
Ren Fail; 2015 Nov; 37(10):354-8. PubMed ID: 26375508
[TBL] [Abstract][Full Text] [Related]
14. How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
Lee AS; Viseshsindh W; Long CJ; Frazier JR; Moran MH; Zderic SA; Weiss DA
J Pediatr Urol; 2020 Apr; 16(2):168.e1-168.e6. PubMed ID: 32115375
[TBL] [Abstract][Full Text] [Related]
15. Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study.
Ciani O; Arendsen E; Romancik M; Lunik R; Costantini E; Di Biase M; Morgia G; Fragalà E; Roman T; Bernat M; Guazzoni G; Tarricone R; Lazzeri M
BMJ Open; 2016 Mar; 6(3):e009669. PubMed ID: 27033958
[TBL] [Abstract][Full Text] [Related]
16. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E
BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411
[TBL] [Abstract][Full Text] [Related]
17. Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review.
Ziadeh T; Chebel R; Labaki C; Saliba G; Helou EE
Urologia; 2022 May; 89(2):261-267. PubMed ID: 34612750
[TBL] [Abstract][Full Text] [Related]
18. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis.
Goddard JC; Janssen DAW
Int Urogynecol J; 2018 Jul; 29(7):933-942. PubMed ID: 29181550
[TBL] [Abstract][Full Text] [Related]
19. Profiling the Urobiota in a Pediatric Population with Neurogenic Bladder Secondary to Spinal Dysraphism.
De Maio F; Grotti G; Mariani F; Buonsenso D; Santarelli G; Bianco DM; Posteraro B; Sanguinetti M; Rendeli C
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175968
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
